An article by HIGHMARK co-founder Anthony Sannazzaro, “MRSA: The Superbug Poised to Cost Hospitals Super Sums,” was featured in Infection Control Today. The article explains that new 2017 MRSA rules are poised to cost hospitals hundreds of millions of dollars in lost Medicare reimbursements. However, this ill-fated financial scenario can be avoided if hospitals install the right air-treatment technology, such as a Photocatalytic Oxidation (PCO) system, to eliminate MRSA. Not only will hospitals avoid massive financial losses, the health of their patients will be significantly enhanced.
To view the full article in Infection Control Today, click here.